Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Alexandre

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 26, 2021
ST-segment/heart rate hysteresis improves the exercise testing accuracy for coronary artery detection in asymptomatic patients with severe aortic stenosisAntonio Procopio, Francesco Radico, Joachim Alexandre, et al.
Journal of the American Heart Association|September 7, 2020
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology GuidelinesJoachim Alexandre, Jennifer Cautela, Stéphane Ederhy, et al.
Journal of the American Heart Association|November 13, 2019
Effects of Mineralocorticoid Receptor Antagonists on Atrial Fibrillation Occurrence: A Systematic Review, Meta-Analysis, and Meta-Regression to Identify Modifying FactorsJoachim Alexandre, Charles Dolladille, Laurent Douesnel, et al.
Biomedicines|September 27, 2025
Association Between the Renin-Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort StudyJonaz Font, Amir Hodzic, Angélique Da-Silva, et al.
American Heart Journal|June 8, 2019
Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trialJoachim Alexandre, Pierre Ollitrault, Marc-Olivier Fischer, et al.
JAMA Oncology|April 17, 2020
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With CancerCharles Dolladille, Stéphane Ederhy, Marion Sassier, et al.
Open Heart|June 7, 2019
High incidence of atrial fibrillation in patients treated with ibrutinibFlorian Baptiste, Jennifer Cautela, Yan Ancedy, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 1, 2020
Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance databaseJoachim Alexandre, Joe-Elie Salem, Javid Moslehi, et al.
Journal of Hypertension|September 2, 2016
Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: a prospective cohort studyJoachim Alexandre, Eric Saloux, Mathieu Chequel, et al.
Circulation|November 1, 2021
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor MyocarditisJohn R Power, Joachim Alexandre, Arrush Choudhary, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 26, 2021
ST-segment/heart rate hysteresis improves the exercise testing accuracy for coronary artery detection in asymptomatic patients with severe aortic stenosisAntonio Procopio, Francesco Radico, Joachim Alexandre, et al.
Journal of the American Heart Association|September 7, 2020
Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology GuidelinesJoachim Alexandre, Jennifer Cautela, Stéphane Ederhy, et al.
Journal of the American Heart Association|November 13, 2019
Effects of Mineralocorticoid Receptor Antagonists on Atrial Fibrillation Occurrence: A Systematic Review, Meta-Analysis, and Meta-Regression to Identify Modifying FactorsJoachim Alexandre, Charles Dolladille, Laurent Douesnel, et al.
Biomedicines|September 27, 2025
Association Between the Renin-Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort StudyJonaz Font, Amir Hodzic, Angélique Da-Silva, et al.
American Heart Journal|June 8, 2019
Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trialJoachim Alexandre, Pierre Ollitrault, Marc-Olivier Fischer, et al.
JAMA Oncology|April 17, 2020
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With CancerCharles Dolladille, Stéphane Ederhy, Marion Sassier, et al.
Open Heart|June 7, 2019
High incidence of atrial fibrillation in patients treated with ibrutinibFlorian Baptiste, Jennifer Cautela, Yan Ancedy, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 1, 2020
Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance databaseJoachim Alexandre, Joe-Elie Salem, Javid Moslehi, et al.
Journal of Hypertension|September 2, 2016
Preoperative plasma aldosterone and the risk of atrial fibrillation after coronary artery bypass surgery: a prospective cohort studyJoachim Alexandre, Eric Saloux, Mathieu Chequel, et al.
Circulation|November 1, 2021
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor MyocarditisJohn R Power, Joachim Alexandre, Arrush Choudhary, et al.
Pageof 15